Please enable JavaScript to continue using this application.

Compare $FBIO vs $RNTX | Chartloom

Compare

$FBIO vs $RNTX

Fortress Biotech Inc · Rein Therapeutics Inc

FBIO

Fortress Biotech Inc

RNTX

Rein Therapeutics Inc

Compare $FBIO vs $RNTX

Comparing Fortress Biotech Inc and Rein Therapeutics Inc

FBIOFortress Biotech Inc

RNTXRein Therapeutics Inc

FBIOFortress Biotech Inc

Market cap

$71M

P/E (TTM)

0.66x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

15.5%

YTD performance

-47.0%

52W performance

-26.6%

FCF yield

1.8%

RNTXRein Therapeutics Inc

Market cap

$68M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.5%

52W performance

-42.9%

FCF yield

-27.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FBIO

RNTX

Detailed metrics comparison

FBIO

Fortress Biotech Inc

RNTX

Rein Therapeutics Inc

Market Cap

FBIO$71M

RNTX$68M

Enterprise Value

FBIO$-86M

RNTX$59M

Price

FBIO$2.14

RNTX$0.79

P/E Ratio

FBIO0.66x

RNTXN/A

P/S Ratio

FBIO1.04x

RNTX0.00x

EV/Sales

FBIO-1.26x

RNTX0.00x

EV/EBITDA

FBIO0.00x

RNTX0.00x

P/B Ratio

FBIO0.41x

RNTX1.25x

P/FCF Ratio

FBIO0.56x

RNTXN/A

EV/FCF

FBIO-0.68x

RNTX-3.15x

PEG Ratio

FBION/A

RNTXN/A

Forward P/E (NTM)

FBION/A

RNTXN/A

Forward P/S (NTM)

FBION/A

RNTXN/A

Revenue (TTM)

FBIO$68M

RNTX$0

Revenue Growth (YoY)

FBIO15.5%

RNTXN/A

Forward Rev Growth

FBIO43.7%

RNTX113.7%

Gross Margin (TTM)

FBIO65.6%

RNTX0.0%

Operating Margin (TTM)

FBIO0.0%

RNTX0.0%

EBITDA Margin (TTM)

FBIO-36.1%

RNTX0.0%

Net Margin (TTM)

FBIO151.0%

RNTX0.0%

FCF Margin (TTM)

FBIO183.8%

RNTXN/A

Net Income (TTM)

FBIO$103M

RNTX$-50M

FCF (TTM)

FBIO$126M

RNTX$-19M

EPS (TTM)

FBIO$3.25

RNTX-$0.74

ROE (TTM)

FBIO103.5%

RNTX-15323.0%

ROA (TTM)

FBIO43.0%

RNTX-11700.0%

ROIC (TTM)

FBIO71.7%

RNTX-14763.0%

Cash

FBIO$197M

RNTX$9M

Debt

FBIO$40M

RNTX$0

Net Cash/Debt

FBIO$157M

RNTX$9M

Current Ratio (TTM)

FBIO3.96x

RNTX4.27x

Quick Ratio (TTM)

FBIO3.76x

RNTX4.26x

Debt/Equity (TTM)

FBIO0.24x

RNTX0.00x

Debt/Assets (TTM)

FBIO0.0%

RNTX0.0%

Interest Coverage (TTM)

FBION/A

RNTXN/A

Net Debt/EBITDA (TTM)

FBIO0.00x

RNTX0.00x

Beta

FBIO1.23

RNTX1.40

52W Performance

FBIO-26.6%

RNTX-42.9%

YTD Performance

FBIO-47.0%

RNTX-36.5%

% from 52W High

FBIO-52.9%

RNTX-63.6%

% from 52W Low

FBIO6.7%

RNTX14.4%

Asset Turnover (TTM)

FBIO0.26x

RNTX0.00x

FCF Yield (TTM)

FBIO1.8%

RNTX-27.7%

Earnings Yield (TTM)

FBIO145.7%

RNTX-73.3%

Dividend Yield (TTM)

FBIO0.7%

RNTXN/A

Rule of 40

FBIO199.3

RNTX0.0

EV/GP/RG

FBION/A

RNTXN/A

Ticker research

View FBIO research View RNTX research

Metric	FBIO Fortress Biotech Inc	RNTX Rein Therapeutics Inc
Market & Valuation
Market Cap	$71M	$68M
Enterprise Value	$-86M	$59M
Price	$2.14	$0.79
P/E Ratio	0.66x	N/A
P/S Ratio	1.04x	0.00x
EV/Sales	-1.26x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.41x	1.25x
P/FCF Ratio	0.56x	N/A
EV/FCF	-0.68x	-3.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$68M	$0
Revenue Growth (YoY)	15.5%	N/A
Forward Rev Growth	43.7%	113.7%
Profitability
Gross Margin (TTM)	65.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-36.1%	0.0%
Net Margin (TTM)	151.0%	0.0%
FCF Margin (TTM)	183.8%	N/A
Net Income (TTM)	$103M	$-50M
FCF (TTM)	$126M	$-19M
EPS (TTM)	$3.25	-$0.74
ROE (TTM)	103.5%	-15323.0%
ROA (TTM)	43.0%	-11700.0%
ROIC (TTM)	71.7%	-14763.0%
Financial Health
Cash	$197M	$9M
Debt	$40M	$0
Net Cash/Debt	$157M	$9M
Current Ratio (TTM)	3.96x	4.27x
Quick Ratio (TTM)	3.76x	4.26x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.23	1.40
52W Performance	-26.6%	-42.9%
YTD Performance	-47.0%	-36.5%
% from 52W High	-52.9%	-63.6%
% from 52W Low	6.7%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.00x
FCF Yield (TTM)	1.8%	-27.7%
Earnings Yield (TTM)	145.7%	-73.3%
Dividend Yield (TTM)	0.7%	N/A
Other
Rule of 40	199.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FBIO research	View RNTX research

Valuation

P/E Ratio

FBIO

0.66x

P/S Ratio

RNTX

0.00x

FBIO

1.04x

EV/FCF

RNTX

-3.15x

FBIO

-0.68x

Growth & revenue

Revenue Growth TTM

FBIO

15.5%

Forward Revenue Growth

RNTX

113.7%

FBIO

43.7%

Profitability & performance

Gross Margin

FBIO

65.6%

RNTX

0.0%

ROE

FBIO

103.5%

RNTX

-15323.0%

FCF Yield %

FBIO

1.8%

RNTX

-27.7%

52-Week Performance

FBIO

-26.6%

RNTX

-42.9%

Detailed metrics comparison

FBIO

Fortress Biotech Inc

RNTX

Rein Therapeutics Inc

Market Cap

FBIO$71M

RNTX$68M

Enterprise Value

FBIO$-86M

RNTX$59M

Price

FBIO$2.14

RNTX$0.79

P/E Ratio

FBIO0.66x

RNTXN/A

P/S Ratio

FBIO1.04x

RNTX0.00x

EV/Sales

FBIO-1.26x

RNTX0.00x

EV/EBITDA

FBIO0.00x

RNTX0.00x

P/B Ratio

FBIO0.41x

RNTX1.25x

P/FCF Ratio

FBIO0.56x

RNTXN/A

EV/FCF

FBIO-0.68x

RNTX-3.15x

PEG Ratio

FBION/A

RNTXN/A

Forward P/E (NTM)

FBION/A

RNTXN/A

Forward P/S (NTM)

FBION/A

RNTXN/A

Revenue (TTM)

FBIO$68M

RNTX$0

Revenue Growth (YoY)

FBIO15.5%

RNTXN/A

Forward Rev Growth

FBIO43.7%

RNTX113.7%

Gross Margin (TTM)

FBIO65.6%

RNTX0.0%

Operating Margin (TTM)

FBIO0.0%

RNTX0.0%

EBITDA Margin (TTM)

FBIO-36.1%

RNTX0.0%

Net Margin (TTM)

FBIO151.0%

RNTX0.0%

FCF Margin (TTM)

FBIO183.8%

RNTXN/A

Net Income (TTM)

FBIO$103M

RNTX$-50M

FCF (TTM)

FBIO$126M

RNTX$-19M

EPS (TTM)

FBIO$3.25

RNTX-$0.74

ROE (TTM)

FBIO103.5%

RNTX-15323.0%

ROA (TTM)

FBIO43.0%

RNTX-11700.0%

ROIC (TTM)

FBIO71.7%

RNTX-14763.0%

Cash

FBIO$197M

RNTX$9M

Debt

FBIO$40M

RNTX$0

Net Cash/Debt

FBIO$157M

RNTX$9M

Current Ratio (TTM)

FBIO3.96x

RNTX4.27x

Quick Ratio (TTM)

FBIO3.76x

RNTX4.26x

Debt/Equity (TTM)

FBIO0.24x

RNTX0.00x

Debt/Assets (TTM)

FBIO0.0%

RNTX0.0%

Interest Coverage (TTM)

FBION/A

RNTXN/A

Net Debt/EBITDA (TTM)

FBIO0.00x

RNTX0.00x

Beta

FBIO1.23

RNTX1.40

52W Performance

FBIO-26.6%

RNTX-42.9%

YTD Performance

FBIO-47.0%

RNTX-36.5%

% from 52W High

FBIO-52.9%

RNTX-63.6%

% from 52W Low

FBIO6.7%

RNTX14.4%

Asset Turnover (TTM)

FBIO0.26x

RNTX0.00x

FCF Yield (TTM)

FBIO1.8%

RNTX-27.7%

Earnings Yield (TTM)

FBIO145.7%

RNTX-73.3%

Dividend Yield (TTM)

FBIO0.7%

RNTXN/A

Rule of 40

FBIO199.3

RNTX0.0

EV/GP/RG

FBION/A

RNTXN/A

Ticker research

View FBIO research View RNTX research

Metric	FBIO Fortress Biotech Inc	RNTX Rein Therapeutics Inc
Market & Valuation
Market Cap	$71M	$68M
Enterprise Value	$-86M	$59M
Price	$2.14	$0.79
P/E Ratio	0.66x	N/A
P/S Ratio	1.04x	0.00x
EV/Sales	-1.26x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.41x	1.25x
P/FCF Ratio	0.56x	N/A
EV/FCF	-0.68x	-3.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$68M	$0
Revenue Growth (YoY)	15.5%	N/A
Forward Rev Growth	43.7%	113.7%
Profitability
Gross Margin (TTM)	65.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-36.1%	0.0%
Net Margin (TTM)	151.0%	0.0%
FCF Margin (TTM)	183.8%	N/A
Net Income (TTM)	$103M	$-50M
FCF (TTM)	$126M	$-19M
EPS (TTM)	$3.25	-$0.74
ROE (TTM)	103.5%	-15323.0%
ROA (TTM)	43.0%	-11700.0%
ROIC (TTM)	71.7%	-14763.0%
Financial Health
Cash	$197M	$9M
Debt	$40M	$0
Net Cash/Debt	$157M	$9M
Current Ratio (TTM)	3.96x	4.27x
Quick Ratio (TTM)	3.76x	4.26x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.23	1.40
52W Performance	-26.6%	-42.9%
YTD Performance	-47.0%	-36.5%
% from 52W High	-52.9%	-63.6%
% from 52W Low	6.7%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.00x
FCF Yield (TTM)	1.8%	-27.7%
Earnings Yield (TTM)	145.7%	-73.3%
Dividend Yield (TTM)	0.7%	N/A
Other
Rule of 40	199.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FBIO research	View RNTX research